Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
TARRYTOWN, N.Y., May 3, 2013 — /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced financial and operating results for the first quarter of 2013 and provided an update on development programs.
The Company reported total revenues of $440 million in the first quarter of 2013, compared to $232 million in the first quarter of 2012.
Help employers find you! Check out all the jobs and post your resume.
